动脉瘤性蛛网膜下腔出血相关应激性心肌病的诊疗进展  

Progress of diagnosis and treatment of stress cardiomyopathy induced by aneurismal subarachnoid hemorrhage

作　　者：郭小蕊 齐猛[2] 徐跃峤[2] Guo Xiaorui;Qi Meng;Xu Yueqiao(Intensive Care Unit,Shijiazhuang Ping′an Hospital,Shijiazhuang 050000,China)

机构地区：[1]石家庄平安医院重症监护室,050000 [2]首都医科大学宣武医院神经外科监护室

出　　处：《中国脑血管病杂志》2020年第1期49-53,共5页Chinese Journal of Cerebrovascular Diseases

基　　金：北京市教育委员会科技计划(KM201710025015)

摘　　要：应激性心肌病是由应激诱发的短暂性左心室基底部或心尖部室壁运动减退或运动障碍,该病多由各种应激因素所促发,如神经源性因素卒中、动脉瘤性蛛网膜下腔出血等,蛛网膜下腔出血中应激性心肌病发生率较高。作者从表现形式、病理生理机制、治疗、预后等方面对蛛网膜下腔出血应激性心肌病进行综述,以提高临床对该疾病的关注和认识。Stress cardiomyopathy is a transient left ventricular basal or apical wall motion loss or dyskinesia induced by stress reaction.The disease is often caused by various stress factors such as neurogenic stroke,aneurismal subarachnoid hemorrhage,and so forth.The incidence of stress cardiomyopathy caused by subarachnoid hemorrhage is higher than other stress factors.This review describes stress cardiomyopathy caused by subarachnoid hemorrhage from the symptom,pathophysiological mechanism,treatment,and prognosis,aiming to improve the clinical attention and understanding of this disease.

关 键 词：动脉瘤性蛛网膜下腔出血 应激性心肌病 诊疗进展 综述 

分 类 号：R743.35[医药卫生—神经病学与精神病学] R542.2[医药卫生—临床医学]